LATEST ALERTS
Sweden: The government has notified two bills (2024/0596/SE and 2024/0597/SE), which aim to classify several cannabinoids as narcotics, to the European Commission’s TRIS
New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
Sign Up
Access our regulatory alerts and get timely notifications sent to your inbox for 7 days
Your display name will appear here.
Please enter a username.
Sweden: In December 2021, the government tasked the Swedish Medical Products Agency with drafting a report on low-THC products, which it recently published. The
Sweden: Hexahydrocannabinol (HHC) and hexahydrocannabiphorol (HHCP), which are currently unregulated, will be classified as narcotics starting tomorrow, 11th July. At the beginning of
Sweden: The Public Health Agency has proposed that the government should classify hexahydrocannabinol (HHC) and hexahydrocannabiphorol (HHCP) as narcotics. HHC and HHCP, currently
Sweden: The Public Health Agency has added H4-CBD, a hydrogenated version of CBD, to the list of substances under investigation, while hexahydrocannabinol (HHC)
EU: The Swedish Medical Products Agency (SMPA), the representative for Sweden in the Working Group on Cosmetic Products of the European Commission (EC), told CannIntelligence
EU: The Directorate General for Internal Market, Industry, Entrepreneurship and SMEs has told CannIntelligence that some EU member states expressed concerns during the 1st March meeting of the Working Group
EU: The minutes of the 1st March 2022 meeting of the Working Group on Cosmetic Products have been published this week. While discussing CBD in cosmetic products, Ireland “commented
Sweden: The European Court of Human Rights (ECHR) has sided with Sweden in a case involving medical cannabis, ruling that there has been
Sweden: An administrative court in Stockholm ruled in favour of the Medical Products Agency that banned a Dutch company from selling CBD-containing products
